A cessation program for snuff-dippers with long-term, extensive exposure to Swedish moist snuff: A 1-year follow-up study

Acta Odontologica Scandinavica

Volumn 68, Issue 6, 2010, Pages 377-384

  Wallström, Mats ^a   Bolinder, Gunilla ^b   Hasséus, Bengt ^a   Hirsch, Jan M ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cessation; Nicotine replacement; Oral mucosa; Smokeless tobacco; Snus

Indexed keywords

DRUG DERIVATIVE; NICOTINE; NICOTINE GUM; NICOTINIC AGENT; POLYMETHACRYLIC ACID DERIVATIVE; POLYVINYL DERIVATIVE;

ADULT; ARTICLE; CLINICAL TRIAL; COUNSELING; HUMAN; METHODOLOGY; MIDDLE AGED; MOTIVATION; NONPARAMETRIC TEST; PROSPECTIVE STUDY; SMOKELESS TOBACCO; SMOKING CESSATION; SWEDEN; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

ADULT; COUNSELING; HUMANS; MIDDLE AGED; MOTIVATION; NICOTINE; NICOTINIC AGONISTS; POLYMETHACRYLIC ACIDS; POLYVINYLS; PROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SWEDEN; TOBACCO USE CESSATION; TOBACCO USE DISORDER; TOBACCO, SMOKELESS; TREATMENT OUTCOME;

EID: 77958065846     PISSN: 00016357     EISSN: 15023850     Source Type: Journal    
DOI: 10.3109/00016357.2010.514734     Document Type: Article

References (47)

1. Wadman C. Nationella folkhälsoenkäten. In: Health SIoNP, editor. Nationella folkhälsoenkäten-Hälsa på lika villkor. Sundsvall, Sweden: Statens folkhälsoinstitut; 2008. p. 2-5. Available at: http://www.fhi.se.
2. Richter P, Hodge K, Stanfill S, Zhang L, Watson C. Surveillance of moist snuff: total nicotine, moisture, pH, un-ionized nicotine, and tobacco-specific nitrosamines. Nicotine Tob Res 2008;10:1645-52.
3. Hirsch JM, Heyden G, Thilander H. A clinical, histomorphological and histochemical study on snuff-induced lesions of varying severity. J Oral Pathol 1982;11:387-98.
4. Andersson G, Bjornberg G, Curvall M. Oral mucosal changes and nicotine disposition in users of Swedish smokeless tobacco products: a comparative study. J Oral Pathol Med 1994;23:161-7.
5. Namn IARC, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 89. Lyon France: Smokeless Tobacco and Some Tobacco-specific N-Nitrosamines; 2007.
6. Pindborg JJ, Poulsen HE. Studies in oral leukoplakias. I. The influence of snuff upon the connective tissue of the oral mucosa. Preliminary report. Acta Pathol Microbiol Scand 1962;55:412-4.
7. Pindborg JJ. Studies in oral leukoplakias II. Effect on snuff on oral epithelium. Acta Dermatol Venereol 1963;43:271-6.
8. Wedenberg C, Jonsson A, Hirsch JM. Assessment of p53 and Ki-67 expression in snuff-induced lesions. Br J Oral Maxillofac Surg 1996;34:409-13.
9. Bolinder G, Alfredsson L, Englund A, de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Publ Health 1994;84:399-404.
10. Bolinder G. Overview of knowledge of health effects of smokeless tobacco. Increased risk of cardiovascular diseases and mortality because of snuff. Lakartidningen 1997;94:3725-31 (in Swedish).
11. Bolinder G, Noren A, de Faire U, Wahren J. Smokeless tobacco use and atherosclerosis: an ultrasonographic investigation of carotid intima media thickness in healthy middleaged men. Atherosclerosis 1997;132:95-103.
12. Critchley JA, Unal B. Health effects associated with smokeless tobacco: a systematic review. Thorax 2003;58:435-43.
13. Roosaar A, Johansson AL, Sandborgh-Englund G, Axell T, Nyren O. Cancer and mortality among users and nonusers of snus. Int J Cancer 2008;123:168-73.
14. Little SJ, Stevens VJ, Severson HH, Lichtenstein E. Effective smokeless tobacco intervention for dental hygiene patients. J Dent Hyg 1992;66:185-90.
15. Darmody DL, Ehrich B. Snuffing it out: a smokeless tobacco intervention with athletes at a small private college. J Am Coll Health 1994;43:27-30.
16. Sinusas K, Coroso JG. Smokeless tobacco cessation: report of a preliminary trial using nicotine chewing gum. J Fam Pract 1993;37:264-7.
17. Hatsukami D, Jensen J, Allen S, Grillo M, Bliss R. Effects of behavioral and pharmacological treatment on smokeless tobacco users. J Consult Clin Psychol 1996;64:153-61.
18. Severson HH, Hatsukami D. Smokeless tobacco cessation. Prim Care 1999;26:529-51.
19. Ebbert JO, Dale LC, Severson H, Croghan IT, Rasmussen DF, Schroeder DR, et al. Nicotine lozenges for the treatment of smokeless tobacco use. Nicotine Tob Res 2007;9:233-40. (Pubitemid 47009069)
20. Kottke TE, Battista RN, DeFriese GH, Brekke ML. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA 1988;259:2883-9.
21. Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2004; (3): CD000146.
22. Carr AB, Ebbert JO. Interventions for tobacco cessation in the dental setting. A systematic review. Commun Dent Health 2007;24:70-4.
23. Hurt RD, Ebbert JO, Hays JT, McFadden DD. Treating tobacco dependence in a medical setting. CA Cancer J Clin 2009;59:314-26.
24. Ebbert JO, Rowland LC, Montori V, Vickers KS, Erwin PC, Dale LC, et al. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev 2004; (3): CD004306.
25. SBU. Metoder för rökavvänjning. Stockholm, Sweden: The Swedish Council on Technology Assessment in Health Care; 1998.
26. Hjalmarson A. Evaluation of supportive strategies with special references to nicotine replacement therapy [Thesis]. Göteborg, Sweden: Göteborg Universitet; 1996.
27. Stevens VJ, Severson H, Lichtenstein E, Little SJ, Leben J. Making the most of a teachable moment: a smokeless-tobacco cessation intervention in the dental office. Am J Publ Health 1995;85:231-5.
28. Glover ED, Glover P. Smokeless tobacco or health: an international prospective. In: Novello AC, editor. Smokeless tobacco cessation and nicotine reduction therapy. Bethesda, Maryland, USA: Smokeless Tobacco and Health, National Institute of Health; 1993. p. 291-6.
29. Holm H, Jarvis MJ, Russell MA, Feyerabend C. Nicotine intake and dependence in Swedish snuff takers. Psychopharmacology (Berl) 1992;108:507-11.
30. Frances A. Diagnostic and statistical manual of mental disorders (DSM-IV), 4th ed. Washington D. C.: American Psychiatric Association; 1994.
31. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine Tob Res 2002;4:149-59.
32. Axell T. A prevalence study of oral mucosal lesions in an adult Swedish population. Odontol Revy Suppl 1976;27:1-103.
33. Altman D. Practical statistics for medical research. Dordrecht, Netherlands: Chapman & Hall; 1992.
34. Wallstrom M, Nilsson F, Hirsch JM. A randomized, doubleblind, placebo-controlled clinical evaluation of a nicotine sublingual tablet in smoking cessation. Addiction 2000;95:1161-71.
35. Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, et al. Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 1988;318:15-18.
36. Benowitz N. Pharmacology of smokeless tobacco use: nicotine addiction and nicotine-related health consequences. In: Novello AC, editor. Smokeless tobacco cessation and nicotine reduction therapy. Bethesda, Maryland, USA: Smokeless Tobacco and Health, National Institute of Health; 1993. p. 219-28.
37. Fagerstrom KO. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment. Addict Behav 1978;3:235-41.
38. Ebbert JO, Montori V, Vickers KS, Erwin PC, Dale LC, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev 2007; (4): CD004306.
39. Gordon JS, Lichtenstein E, Severson HH, Andrews JA. Tobacco cessation in dental settings: research findings and future directions. Drug Alcohol Rev 2006;25:27-37.
40. Jensen EJ, Schmidt E, Pedersen B, Dahl R. Effect on smoking cessation of silver acetate, nicotine and ordinary chewing gum. Influence of smoking history. Psychopharmacology (Berl) 1991;104:470-4.
41. Hjalmarson A, Nilsson F, Sjostrom L, Wiklund O. The nicotine inhaler in smoking cessation. Arch Intern Med 1997;157:1721-8.
42. Kornitzer M, Boutsen M, Dramaix M, Thijs J, Gustavsson G. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995;24:41-7.
43. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994;308:21-6.
44. Murray RP, Bailey WC, Daniels K, Bjornson WM, Kurnow K, Connett JE, et al. Safety of nicotine polacrilex gum used by 3, 094 participants in the Lung Health Study. Lung Health Study Research Group. Chest 1996;109:438-45.
45. Wallstrom M, Sand L, Nilsson F, Hirsch JM. The long-term effect of nicotine on the oral mucosa. Addiction 1999;94:417-23.
46. Bolinder GM, Ahlborg BO, Lindell JH. Use of smokeless tobacco: blood pressure elevation and other health hazards found in a large-scale population survey. J Intern Med 1992;232:327-34.
47. Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K. The influence of smoking and smokeless tobacco use on weight amongst men. J Intern Med 2004;255:102-7.